Pericytes, microvasular dysfunction, and chronic rejection

Chronic rejection of transplanted organs remains themain obstacle in the long-termsuccess of organ transplantation. Thus, there is a persistent quest for development of antichronic rejection therapies and identification of novelmolecular and cellular targets. One of the potential targets is the pericytes, the mural cells of microvessels, which regulate microvascular permeability, development, and maturation by controlling endothelial cell functions and regulating tissue fibrosis and inflammatory response. In this review, we discuss the potential of targeting pericytes in the development of microvasular dysfunction and the molecular pathways involved in regulation of pericyte activities for antichronic rejection intervention.